Free Trial

Treace Medical Concepts Q3 2024 Earnings Report

Treace Medical Concepts logo
$8.45 +0.08 (+0.96%)
As of 03/28/2025 04:00 PM Eastern

Treace Medical Concepts EPS Results

Actual EPS
-$0.25
Consensus EPS
-$0.27
Beat/Miss
Beat by +$0.02
One Year Ago EPS
-$0.28

Treace Medical Concepts Revenue Results

Actual Revenue
$45.09 million
Expected Revenue
$43.48 million
Beat/Miss
Beat by +$1.61 million
YoY Revenue Growth
+10.60%

Treace Medical Concepts Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Remove Ads

Treace Medical Concepts Earnings Headlines

DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.
See More Treace Medical Concepts Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Treace Medical Concepts? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Treace Medical Concepts and other key companies, straight to your email.

About Treace Medical Concepts

Treace Medical Concepts (NASDAQ:TMCI), a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

View Treace Medical Concepts Profile

More Earnings Resources from MarketBeat